Teva Parenteral Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?
TEVA PARENTERAL has forty-seven approved drugs.
Summary for Teva Parenteral
US Patents: | 0 |
Tradenames: | 39 |
Ingredients: | 37 |
NDAs: | 47 |
Patent Litigation for Teva Parenteral: | See patent lawsuits for Teva Parenteral |
Drugs and US Patents for Teva Parenteral
Expired US Patents for Teva Parenteral
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-001 | Approved Prior to Jan 1, 1982 | 3,444,294 | See Plans and Pricing |
Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-002 | Approved Prior to Jan 1, 1982 | 3,444,294 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.